Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

So far, Altmetric has seen 14 X posts from 7 X users, with an upper bound of 23,748 followers.

Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054. https://t.co/sAfxg6O7ue

RT @sitcancer: #JITC Research: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054 https:…

RT @sitcancer: #JITC Research: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054 https:…

#JITC Research: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054 https://t.co/2xOVfaXPU8 https://t.co/mQoT5PL8cH

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.